Your search returned 3 results.

Results
	1.	Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice. [electronic resource] by Berger, Jean-Mathieu Loza Valdes, Angel Gromada, Jesper Anderson, Norma Horton, Jay D Producer: 20180328 In: Journal of lipid research vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension. [electronic resource] by Berger, Jean-Mathieu Vaillant, Nathalie Le May, Cédric Calderon, Carolina Brégeon, Jeremy Prieur, Xavier Hadchouel, Juliette Loirand, Gervaise Cariou, Bertrand Producer: 20160331 In: Atherosclerosis vol. 239 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1. [electronic resource] by Le May, Cédric Berger, Jean Mathieu Lespine, Anne Pillot, Bruno Prieur, Xavier Letessier, Eric Hussain, M Mahmood Collet, Xavier Cariou, Bertrand Costet, Philippe Producer: 20130827 In: Arteriosclerosis, thrombosis, and vascular biology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search